Study testing a new treatment for immune-related kidney disease
Part of Immune system & allergy clinical trials.
This trial tests a new medicine called STR-P004 for people with kidney diseases caused by the immune system attacking the kidneys. The study checks if the medicine is safe and if the body can tolerate it, which may help reduce kidney damage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You must have a type of kidney disease caused by the immune system attacking your kidneys, like lupus nephritis or ANCA vasculitis.
- A blood test must show you have a certain type of immune cell called CD19-positive B cells.
- Your vital organs (bone marrow, liver, blood clotting, and lungs) must be working well enough.
- You must agree to use effective birth control during the study and for one year after the treatment.
- You must not have other serious health problems unrelated to your kidney disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests the safety of a new treatment called STR-P004 for people with systemic lupus erythematosus (SLE) or certain inflammatory muscle diseases that have not improved with standard therapies. It may be an option if your condition is hard to control.
This study tests a new treatment (STR-P005) for autoimmune diseases. It aims to selectively target and deplete B cells that carry a specific marker, CD19, which may help reduce disease activity.
This study tests an experimental drug called STR-P005 for people with diseases that affect B cells, such as certain autoimmune or blood disorders. The goal is to see if the drug is safe and if it helps reduce your disease symptoms.
This trial tests a new medicine called LP-005 for people with kidney disease caused by an overactive part of the immune system called the complement system. It aims to see if the drug is safe and effective for reducing kidney damage.
This trial tests a special cell treatment (CAR-T) for people with immune-related kidney disease that has not responded to standard therapy. The treatment aims to remove faulty immune cells that damage the kidneys.
This trial tests a new drug called STR-P004 for adults with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL), a type of blood cancer. The goal is to see if the drug is safe and can help shrink or control the cancer.
Hear when a new Autoimmune Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.